|

Pelacarsen (TQJ230) 80mg Clinical Trials

1 actively recruiting trial across 1 location

Also known as: TQJ230

Pipeline

Phase 2: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • Aortic Stenosis1
  • Heart Disease1

Huntsville, Alabama1 trial

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Heart Center Research Llc

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.